Found: 96
Select item for more details and to access through your institution.
Similar early metabolic changes induced by dietary weight loss or bariatric surgery. Reply to Taylor R [letter].
- Published in:
- 2024
- By:
- Publication type:
- Letter
Insulin resistance in diabetic nephropathy - cause or consequence?
- Published in:
- Diabetes/Metabolism Research & Reviews, 2006, v. 22, n. 5, p. 401, doi. 10.1002/dmrr.648
- By:
- Publication type:
- Article
Is insulin resistance caused by defects in insulin's target cells or by a stressed mind?
- Published in:
- Diabetes/Metabolism Research & Reviews, 2005, v. 21, n. 6, p. 487, doi. 10.1002/dmrr.567
- By:
- Publication type:
- Article
Assessment of Toe Blood Pressure Is an Effective Screening Method to Identify Diabetes Patients with Lower Extremity Arterial Disease.
- Published in:
- Angiology, 2004, v. 55, n. 6, p. 641, doi. 10.1177/00033197040550i605
- By:
- Publication type:
- Article
High glucose and insulin in combination cause insulin receptor substrate-1 and -2 depletion and protein kinase B desensitisation in primary cultured rat adipocytes: possible implications for insulin resistance in type 2 diabetes.
- Published in:
- European Journal of Endocrinology, 2003, v. 148, n. 1, p. 157
- By:
- Publication type:
- Article
Dexamethasone impairs insulin signalling and glucose transport by depletion of insulin receptor substrate-1, phosphatidylinositol 3-kinase and protein kinase B in primary cultured rat adipocytes.
- Published in:
- European Journal of Endocrinology, 2002, v. 146, n. 3, p. 419, doi. 10.1530/eje.0.1460419
- By:
- Publication type:
- Article
Regulation of the Cortisol Axis, Glucagon, and Growth Hormone by Glucose Is Altered in Prediabetes and Type 2 Diabetes.
- Published in:
- Journal of Clinical Endocrinology & Metabolism, 2024, v. 109, n. 2, p. e675, doi. 10.1210/clinem/dgad549
- By:
- Publication type:
- Article
Role of Estrogen and Its Receptors in Adipose Tissue Glucose Metabolism in Pre- and Postmenopausal Women.
- Published in:
- Journal of Clinical Endocrinology & Metabolism, 2022, v. 107, n. 5, p. e1879, doi. 10.1210/clinem/dgac042
- By:
- Publication type:
- Article
Time Course of Metabolic, Neuroendocrine, and Adipose Effects During 2 Years of Follow-up After Gastric Bypass in Patients With Type 2 Diabetes.
- Published in:
- Journal of Clinical Endocrinology & Metabolism, 2021, v. 106, n. 10, p. e4049, doi. 10.1210/clinem/dgab398
- By:
- Publication type:
- Article
The Plasma Metabolomic Profile is Differently Associated with Liver Fat, Visceral Adipose Tissue, and Pancreatic Fat.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Metabolomic Profiling of Adipose Tissue in Type 2 Diabetes: Associations with Obesity and Insulin Resistance.
- Published in:
- Metabolites (2218-1989), 2024, v. 14, n. 8, p. 411, doi. 10.3390/metabo14080411
- By:
- Publication type:
- Article
Several Metabolite Families Display Inflexibility during Glucose Challenge in Patients with Type 2 Diabetes: An Untargeted Metabolomics Study.
- Published in:
- Metabolites (2218-1989), 2023, v. 13, n. 1, p. 131, doi. 10.3390/metabo13010131
- By:
- Publication type:
- Article
Special Issue on Metabolism and Metabolite Markers in Type 2 Diabetes.
- Published in:
- Metabolites (2218-1989), 2022, v. 12, n. 7, p. N.PAG, doi. 10.3390/metabo12070642
- By:
- Publication type:
- Article
Impaired HMG-CoA Reductase Activity Caused by Genetic Variants or Statin Exposure: Impact on Human Adipose Tissue, β-Cells and Metabolome.
- Published in:
- Metabolites (2218-1989), 2021, v. 11, n. 9, p. 574, doi. 10.3390/metabo11090574
- By:
- Publication type:
- Article
Cyclosporine A and Tacrolimus Reduce the Amount of GLUT4 at the Cell Surface in Human Adipocytes: Increased Endocytosis as a Potential Mechanism for the Diabetogenic Effects of Immunosuppressive Agents.
- Published in:
- 2014
- By:
- Publication type:
- Journal Article
Patients with type 1 and type 2 diabetes hospitalized with COVID-19 in comparison with influenza: mortality and cardiorenal complications assessed by nationwide Swedish registry data.
- Published in:
- Cardiovascular Diabetology, 2022, v. 21, n. 1, p. 1, doi. 10.1186/s12933-022-01719-x
- By:
- Publication type:
- Article
Short-term effects of obesity surgery versus low-energy diet on body composition and tissue-specific glucose uptake: a randomised clinical study using whole-body integrated <sup>18</sup>F-FDG-PET/MRI.
- Published in:
- Diabetologia, 2024, v. 67, n. 7, p. 1399, doi. 10.1007/s00125-024-06150-3
- By:
- Publication type:
- Article
Registry-based randomised clinical trials: a remedy for evidence-based diabetes care?
- Published in:
- Diabetologia, 2022, v. 65, n. 10, p. 1575, doi. 10.1007/s00125-022-05762-x
- By:
- Publication type:
- Article
Altered hormonal and autonomic nerve responses to hypo- and hyperglycaemia are found in overweight and insulin-resistant individuals and may contribute to the development of type 2 diabetes.
- Published in:
- Diabetologia, 2021, v. 64, n. 3, p. 641, doi. 10.1007/s00125-020-05332-z
- By:
- Publication type:
- Article
Effects of dapagliflozin and n-3 carboxylic acids on non-alcoholic fatty liver disease in people with type 2 diabetes: a double-blind randomised placebo-controlled study.
- Published in:
- Diabetologia, 2018, v. 61, n. 9, p. 1923, doi. 10.1007/s00125-018-4675-2
- By:
- Publication type:
- Article
Cost of healthcare utilization associated with incident cardiovascular and renal disease in individuals with type 2 diabetes: A multinational, observational study across 12 countries.
- Published in:
- Diabetes, Obesity & Metabolism, 2022, v. 24, n. 7, p. 1277, doi. 10.1111/dom.14698
- By:
- Publication type:
- Article
Lower cardiorenal risk with sodium‐glucose cotransporter‐2 inhibitors versus dipeptidyl peptidase‐4 inhibitors in patients with type 2 diabetes without cardiovascular and renal diseases: A large multinational observational study.
- Published in:
- Diabetes, Obesity & Metabolism, 2021, v. 23, n. 1, p. 75, doi. 10.1111/dom.14189
- By:
- Publication type:
- Article
Heart failure and chronic kidney disease manifestation and mortality risk associations in type 2 diabetes: A large multinational cohort study.
- Published in:
- Diabetes, Obesity & Metabolism, 2020, v. 22, n. 9, p. 1607, doi. 10.1111/dom.14074
- By:
- Publication type:
- Article
A metabolomics‐based molecular pathway analysis of how the sodium‐glucose co‐transporter‐2 inhibitor dapagliflozin may slow kidney function decline in patients with diabetes.
- Published in:
- Diabetes, Obesity & Metabolism, 2020, v. 22, n. 7, p. 1157, doi. 10.1111/dom.14018
- By:
- Publication type:
- Article
Dapagliflozin vs non‐SGLT‐2i treatment is associated with lower healthcare costs in type 2 diabetes patients similar to participants in the DECLARE‐TIMI 58 trial: A nationwide observational study.
- Published in:
- Diabetes, Obesity & Metabolism, 2019, v. 21, n. 12, p. 2651, doi. 10.1111/dom.13852
- By:
- Publication type:
- Article
Dapagliflozin vs non‐SGLT‐2i treatment is associated with lower healthcare costs in type 2 diabetes patients similar to participants in the DECLARE‐TIMI 58 trial: A nationwide observational study.
- Published in:
- Diabetes, Obesity & Metabolism, 2019, v. 21, n. 12, p. 2651, doi. 10.1111/dom.13852
- By:
- Publication type:
- Article
Dapagliflozin and cardiovascular mortality and disease outcomes in a population with type 2 diabetes similar to that of the DECLARE‐TIMI 58 trial: A nationwide observational study.
- Published in:
- Diabetes, Obesity & Metabolism, 2019, v. 21, n. 5, p. 1136, doi. 10.1111/dom.13627
- By:
- Publication type:
- Article
Dapagliflozin is associated with lower risk of cardiovascular events and all‐cause mortality in people with type 2 diabetes (CVD‐REAL Nordic) when compared with dipeptidyl peptidase‐4 inhibitor therapy: A multinational observational study
- Published in:
- Diabetes, Obesity & Metabolism, 2018, v. 20, n. 2, p. 344, doi. 10.1111/dom.13077
- By:
- Publication type:
- Article
Dapagliflozin once daily plus exenatide once weekly in obese adults without diabetes: Sustained reductions in body weight, glycaemia and blood pressure over 1 year.
- Published in:
- Diabetes, Obesity & Metabolism, 2017, v. 19, n. 9, p. 1276, doi. 10.1111/dom.12954
- By:
- Publication type:
- Article
Novel oral glucose-lowering drugs are associated with lower risk of all-cause mortality, cardiovascular events and severe hypoglycaemia compared with insulin in patients with type 2 diabetes.
- Published in:
- Diabetes, Obesity & Metabolism, 2017, v. 19, n. 6, p. 831, doi. 10.1111/dom.12889
- By:
- Publication type:
- Article
Dapagliflozin once-daily and exenatide once-weekly dual therapy: A 24-week randomized, placebo-controlled, phase II study examining effects on body weight and prediabetes in obese adults without diabetes.
- Published in:
- Diabetes, Obesity & Metabolism, 2017, v. 19, n. 1, p. 49, doi. 10.1111/dom.12779
- By:
- Publication type:
- Article
Emerging Role of SGLT-2 Inhibitors for the Treatment of Obesity.
- Published in:
- Drugs, 2019, v. 79, n. 3, p. 219, doi. 10.1007/s40265-019-1057-0
- By:
- Publication type:
- Article
Positional and compositional analysis of saturated, monounsaturated, and polyunsaturated fatty acids in human adipose tissue triglyceride by <sup>13</sup>C nuclear magnetic resonance.
- Published in:
- NMR in Biomedicine, 2023, v. 36, n. 4, p. 1, doi. 10.1002/nbm.4632
- By:
- Publication type:
- Article
Tissue-specific glucose partitioning and fat content in prediabetes and type 2 diabetes: whole-body PET/MRI during hyperinsulinemia.
- Published in:
- European Journal of Endocrinology, 2021, v. 184, n. 6, p. 879, doi. 10.1530/EJE-20-1359
- By:
- Publication type:
- Article
Effects of GLP-1 on counter-regulatory responses during hypoglycemia after GBP surgery.
- Published in:
- European Journal of Endocrinology, 2019, v. 181, n. 2, p. 161, doi. 10.1530/EJE-19-0171
- By:
- Publication type:
- Article
Alterations in heart rate variability during everyday life are linked to insulin resistance. A role of dominating sympathetic over parasympathetic nerve activity?
- Published in:
- Cardiovascular Diabetology, 2016, v. 15, p. 1, doi. 10.1186/s12933-016-0411-8
- By:
- Publication type:
- Article
Signs of dysregulated fibrinolysis precede the development of type 2 diabetes mellitus in a population-based study.
- Published in:
- Cardiovascular Diabetology, 2012, v. 11, n. 1, p. 1, doi. 10.1186/1475-2840-11-152
- By:
- Publication type:
- Article
Integration of whole-body [18F]FDG PET/MRI with non-targeted metabolomics can provide new insights on tissue-specific insulin resistance in type 2 diabetes.
- Published in:
- Scientific Reports, 2020, v. 10, n. 1, p. 1, doi. 10.1038/s41598-020-64524-0
- By:
- Publication type:
- Article
Author Correction: Intra- and inter-individual metabolic profiling highlights carnitine and lysophosphatidylcholine pathways as key molecular defects in type 2 diabetes.
- Published in:
- 2019
- By:
- Publication type:
- Correction Notice
Intra- and inter-individual metabolic profiling highlights carnitine and lysophosphatidylcholine pathways as key molecular defects in type 2 diabetes.
- Published in:
- Scientific Reports, 2019, v. 9, n. 1, p. N.PAG, doi. 10.1038/s41598-019-45906-5
- By:
- Publication type:
- Article
Health care registers can be instrumental for endpoint capture in clinical diabetes trials: example of microvascular complications in Swedish patients with type 2 diabetes.
- Published in:
- Diabetes & Vascular Disease Research, 2023, v. 20, n. 3, p. 1, doi. 10.1177/14791641231179878
- By:
- Publication type:
- Article
Markers of fibrinolysis may predict development of lower extremity arterial disease in patients with diabetes: A longitudinal prospective cohort study with 10 years of follow-up.
- Published in:
- Diabetes & Vascular Disease Research, 2016, v. 13, n. 3, p. 183, doi. 10.1177/1479164115618516
- By:
- Publication type:
- Article
Early glycemic control, age at onset, and development of microvascular complications in childhood-onset type 1 diabetes: a population-based study in northern Sweden.
- Published in:
- 2004
- By:
- Publication type:
- journal article
Early Glycemic Control, Age at Onset, and Development of Microvascular Complications in Childhood-Onset Type 1 Diabets.
- Published in:
- Diabetes Care, 2004, v. 27, n. 4, p. 955, doi. 10.2337/diacare.27.4.955
- By:
- Publication type:
- Article
Signs of Nephropathy May Occur Early in Young Adults With Diabetes Despite Modern Diabetes Management.
- Published in:
- Diabetes Care, 2003, v. 26, n. 10, p. 2903, doi. 10.2337/diacare.26.10.2903
- By:
- Publication type:
- Article
Effect of Dalteparin on Healing of Chronic Foot Ulcers in Diabetic Patients With Peripheral Arterial Occlusive Disease.
- Published in:
- Diabetes Care, 2003, v. 26, n. 9, p. 2575, doi. 10.2337/diacare.26.9.2575
- By:
- Publication type:
- Article
Effect of dalteparin on healing of chronic foot ulcers in diabetic patients with peripheral arterial occlusive disease: a prospective, randomized, double-blind, placebo-controlled study.
- Published in:
- 2003
- By:
- Publication type:
- journal article
The Incidence of Retinopathy 10 Years After Diagnosis in Young Adult People With Diabetes.
- Published in:
- Diabetes Care, 2003, v. 26, n. 2, p. 349, doi. 10.2337/diacare.26.2.349
- By:
- Publication type:
- Article
Inhibition of dipeptidyl peptidase IV improves metabolic control over a 4-week study period in type 2 diabetes.
- Published in:
- 2002
- By:
- Publication type:
- journal article
Inhibition at Dipeptidyl Peptidase IV Improves Metabolic Control Over a 4-Week Study Period in Type 2 Diabetes.
- Published in:
- Diabetes Care, 2002, v. 25, n. 5, p. 869, doi. 10.2337/diacare.25.5.869
- By:
- Publication type:
- Article